Experience in the treatment of hemorrhagic complications in a patient with a new coronavirus infection on the background of anticoagulant therapy

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A 73 - year - old patient with COVID-19, on the 9th day from the start of treatment, against the background of anticoagulant therapy, developed a complication in the form of the spontaneous formation of a hematoma of pre - vesicular tissue with spread to the tissue of the retroperitoneal space. During an emergency operation, a source of bleeding was found - an artery of the bladder wall. In the postoperative period, glucocorticoid therapy, antibiotic therapy, respiratory support, symptomatic treatment were continued. Contrary to temporary guidelines for preventing, diagnosing, and treating COVID-19, anticoagulant drugs were canceled, and repeated transfusions of blood plasma and erythrocyte mass were performed to replenish blood loss and correct the deficiency of coagulation factors. Against the treatment background, the patient recovered. On the 22nd day, the patient was discharged in a satisfactory condition.

Full Text

Restricted Access

About the authors

P. E Krainyukov

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

A. V Demyanenko

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

V. M Skorobogatov

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

K. N Efremov

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

E. A Kim

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

A. A Efremova

The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Moscow, Russia

References

  1. Анаев Э.Х., Княжеская Н.П. Коагулопатия при COVID-19: фокус на антикоагулянтную терапию // Практ. пульмонол. - 2020. - № 1. - С. 3-13.
  2. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 9 (26.10.2020 г.)
  3. Чернов А.А., Клейменова Е.Б., Сычев Д.А. и др. Причины геморрагических осложнений у пациентов стационара, получающих лечебные дозы антикоагулянтов // Клин. фармакол. и тер. - 2018. - Т. 27, № 5. - С. 23-29.
  4. Danzi G.B., Loffi M., Galeazzi G., Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? // Europ. Heart J. - 2020. - Vol. 41 (19). - P. 1858.
  5. Paranjpe I., Fuster V., Lala A. et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 // J. Am. College of Cardiol. - 2020. - Vol. 76, N 1. - P. 122-129.
  6. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia // J. Thromb. Haemost. - 2020. - Vol. 18, N 4. - P. 844-847.

Copyright (c) 2021 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies